Rational use of antibiotics in an intensive care unit: a retrospective study of the impact on clinical outcomes and mortality rate

Background Intensive care units (ICUs) are specialized units where patients with critical conditions are admitted for getting specialized and individualized medical treatment. High mortality rates have been observed in ICUs, but the exact reason and factors affecting the mortality rates have not yet been studied in the local population in Pakistan. Aim This study was aimed to determine rational use of antibiotic therapy in ICU patients and its impact on clinical outcomes and mortality rate. Methods This was a retrospective, longitudinal (cohort) study including 100 patients in the ICU of the largest tertiary care hospital of the capital city of Pakistan. Results It was observed that empiric antibiotic therapy was initiated in 68% of patients, while culture sensitivity test was conducted for only 19% of patients. Thirty-percent of patients developed nosocomial infections and empiric antibiotic therapy was not initiated for those patients (P<0.05). Irrational antibiotic prescribing was observed in 86% of patients, and among them, 96.5% mortality was observed (P<0.05). The overall mortality rate was 83%; even higher mortality rates were observed in patients on a ventilator, patients with serious drug–drug interactions, and patients prescribed with irrational antibiotics or nephrotoxic drugs. Adverse clinical outcomes leading to death were observed to be significantly associated (P<0.05) with irrational antibiotic prescribing, nonadjustment of doses of nephrotoxic drugs, use of steroids, and major drug–drug interactions. Conclusion It was concluded that empiric antibiotic therapy is beneficial in patients and leads to a reduction in the mortality rate. Factors including irrational antibiotic selection, prescribing contraindicated drug combinations, and use of nephrotoxic drugs were associated with high mortality rate and poor clinical outcomes.

[1]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.

[2]  N. Akhtar Hospital acquired infections in a medical intensive care unit. , 2010, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[3]  P. Murney To mix or not to mix – compatibilities of parenteral drug solutions , 2008 .

[4]  Marek Mirski,et al.  Ventilator-associated pneumonia in the ICU , 2014, Critical Care.

[5]  R. Chang,et al.  Renal failure in the intensive care unit: acute kidney injury compared to end-stage renal failure , 2008, Critical care.

[6]  G. Yılmaz,et al.  Factors Impacting the Likelihood of Death in Patients in Intensive Care Unit , 2016 .

[7]  C. Salgado,et al.  Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic-Resistant Gram-Negative Bacteria , 2009, Antimicrobial Agents and Chemotherapy.

[8]  C. Bor,et al.  Ventilator-associated pneumonia in critically ill patients with intensive antibiotic usage , 2015, Pakistan journal of medical sciences.

[9]  L. Nicolle,et al.  Prevention of hospital acquired infections: a practical guide. , 2002 .

[10]  R. Masterton Antibiotic de-escalation. , 2011, Critical care clinics.

[11]  N. Pradhan,et al.  Nosocomial infections in the medical ICU: a retrospective study highlighting their prevalence, microbiological profile and impact on ICU stay and mortality. , 2014, The Journal of the Association of Physicians of India.

[12]  I Mahmood,et al.  Interspecies scaling of renally secreted drugs. , 1998, Life sciences.

[13]  J. Roberts,et al.  Clinical implications of antibiotic pharmacokinetic principles in the critically ill , 2013, Intensive Care Medicine.

[14]  A. Shirali,et al.  Drug-induced impairment of renal function , 2014, International journal of nephrology and renovascular disease.

[15]  N. Damani,et al.  Infection Control at a Government Hospital in Pakistan , 2009 .

[16]  I. Bibi,et al.  Frequency, pattern and etiology of nosocomial infection in intensive care unit: an experience at a tertiary care hospital. , 2008, Journal of Ayub Medical College, Abbottabad : JAMC.

[17]  J. Roberts,et al.  Antibacterial Dosing in Intensive Care , 2006, Clinical pharmacokinetics.

[18]  S. Naseem,et al.  Status of hospital infection control measures at seven major tertiary care hospitals of northern punjab. , 2010, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[19]  M. I. Malik,et al.  Antimicrobial susceptibility pattern of Bacteria isolated from Tracheal secretions in Intensive Care Units admitted Patients of Lahore General Hospital , 2018 .

[20]  B. Yangco,et al.  CDC definitions for nosocomial infections. , 1989, American journal of infection control.

[21]  D. Pittet,et al.  Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. , 1994, JAMA.

[22]  Cecil R. Reynolds,et al.  Physicians' Desk Reference , 2014 .

[23]  D. Sarraf,et al.  Utilization pattern of antimicrobial agents and its culture sensitivity pattern in intensive care units in a tertiary care center in eastern Nepal , 2016 .

[24]  W. Jarvis,et al.  Selected Aspects of the Socioeconomic Impact of Nosocomial Infections: Morbidity, Mortality, Cost, and Prevention , 1996, Infection Control &#x0026; Hospital Epidemiology.

[25]  M. Emmerson,et al.  Antibiotic usage and prescribing policies in the intensive care unit , 2000, Intensive Care Medicine.

[26]  A Bueno-Cavanillas,et al.  Influence of nosocomial infection on mortality rate in an intensive care unit , 1994, Critical care medicine.

[27]  Sushrut S Waikar,et al.  Outcome of critically ill patients with acute kidney injury using the Acute Kidney Injury Network criteria* , 2011, Critical care medicine.

[28]  Pharmaceutical Care Issues in Patients with Atrial Fibrillation Receiving Thromboprophylaxsis , 2014 .

[29]  V. Rosenthal,et al.  Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay. , 2003, American journal of infection control.

[30]  M. Kollef Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time. , 2003, Drugs.